Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Flow Cytometry (FACS) Antibodies

Anti-Human HLA-DRA Antibody (1D09C3), PE (HM812127)

Anti-Human HLA-DRA Antibody (1D09C3), PE
Anti-Human HLA-DRA Antibody (1D09C3), PE
Price(USD): $
Spec:
  • 50T
  • 100T
Number:
Contact us
  • Overview

  • Images

  • References

  • Datasheet

Overview
Catalog No.HM812127
Species reactivityHuman
ApplicationsFCM
Host speciesMouse
IsotypeIgG1, kappa
Clone ID1D09C3
ConjugationPE
Clonality Monoclonal
Target HLA-DRA1, MHC class II antigen DRA, HLA-DRA, HLA class II histocompatibility antigen, DR alpha chain
Endotoxin level Please contact with the lab for this information.
Accession P01903
Form Liquid
Storage buffer 0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Store at 4°C for 12 months. Protect from light. Do not freeze.
Background

HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) is a ~28 kDa protein. An alpha chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the beta chain HLA-DRB, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DR-restricted CD4-positive T cells. This guides antigen-specific T-helper effector functions, both antibody-mediated immune response and macrophage activation, to ultimately eliminate the infectious agents and transformed cells. Typically presents extracellular peptide antigens of 10 to 30 amino acids that arise from proteolysis of endocytosed antigens in lysosomes. In the tumor microenvironment, presents antigenic peptides that are primarily generated in tumor-resident APCs likely via phagocytosis of apoptotic tumor cells or macropinocytosis of secreted tumor proteins.

1. Shams, H. et al. (2004) Journal of immunology (Baltimore, Md. : 1950) 173, 1966-77. PMID: 15265931
2. Röhn, TA. et al. (2004) Nature immunology 5, 909-18. PMID: 15322540
3. Deng, L. et al. (2007) Nature immunology 8, 398-408. PMID: 17334368
4. Kwok, WW. et al. (2012) Journal of immunology (Baltimore, Md. : 1950) 188, 2537-44. PMID: 22327072
5. Scally, SW. et al. (2013) The Journal of experimental medicine 210, 2569-82. PMID: 24190431
6. Muehling, LM. et al. (2016) Journal of immunology (Baltimore, Md. : 1950) 197, 3214-3224. PMID: 27591323
7. Galperin, M. et al. (2018) Science immunology 3. PMID: 29884618
8. Abelin, JG. et al. (2019) Immunity 51, 766-779.e17. PMID: 31495665
9. Stern, LJ. et al. (1994) Nature 368, 215-21. PMID: 8145819
10. Kropshofer, H. et al. (1997) Immunity 6, 293-302. PMID: 9075930
Note For flow cytometric staining, the suggested use of this reagent is 0.5 µg per million cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application. For research use only.
Images
  • Anti-Human HLA-DRA Antibody (1D09C3), PE

    Flow Cytometry

    Flow-cytometry using PE anti-human HLA-DRA antibody. Daudi cells were stained with an irrelevant antibody (Green Histogram) or a PE anti-human HLA-DRA antibody monoclonal antibody (Catalog # HM812127, Red Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list